Stocktoria
Claritev Corp CTEV
Claritev Corp (CTEV) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $965.4M at a -29.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.008 |
| Retained earnings / assets | -0.497 |
| EBIT / assets | 0.006 |
| Equity / liabilities | -0.034 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CTEV | Claritev Corp | 5/9 | -1.67 | — | +3.7% |
| PRTH | Priority Technology Holdings, Inc. | 3/9 | 0.52 | — | +8.3% |
| GETY | Getty Images Holdings, Inc. | 2/9 | -1.63 | — | +4.5% |
| PAYO | Payoneer Global Inc. | 5/9 | 0.27 | 32.9 | +7.7% |
| NUTX | Nutex Health Inc. | 7/9 | 4.62 | 16.2 | +82.4% |
| XBP | XBP Global Holdings, Inc. | 3/9 | — | — | — |
| ANDG | Andersen Group Inc. | 2/9 | -0.11 | — | +14.6% |
About Claritev Corp
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
FAQ
Is CTEV financially healthy?
Claritev Corp's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does CTEV pay a dividend?
No, Claritev Corp does not currently pay a dividend.
How profitable is CTEV?
In FY2025, Claritev Corp had a net margin of -29.4%.
What is the analyst price target for CTEV?
The average Wall-Street price target for Claritev Corp is $36.83, about 4.3% above the recent price, from 6 analysts (consensus: buy).
Is CTEV a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Claritev Corp: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.